Hungary’s Egis Picks Up Skin-Care Portfolio From Teva

Egis is the beneficiary as Teva again trims its OTC portfolio with the sale of Hungarian skin-care brand Neogranormon.

(Shutterstock)

Hungary’s Egis Pharmaceuticals has bolstered its OTC portfolio in its domestic market with the acquisition of skin-care brand Neogranormon from Teva Pharmaceutical Industries for an undisclosed sum.

The acquired Neogranormon portfolio is led by a zinc oxide-based ointment approved as an OTC drug in Hungary, which is said by Egis to stimulate the healing of skin injuries while protecting against the risk of infection

More from Deals

US Beauty Deals: Kim Kardashian Buys Back Beauty Brand Rights From Coty, L’Oréal’s NYX Professional Makeup Teams With Warner Bros.

 

Kim Kardashian lifestyle company SKIMS buys back rights to SKKN by Kim from Coty, Inc., which had purchased a 20% interest in the brand in 2020 for $200m. Separately, NYX Professional Makeup partners with Warner Bros. to launch the “A Minecraft Movie” collection.

L’Oréal Sells ‘Pioneering’ Carol’s Daughter Hair Brand After 20-Year Ownership

 

L’Oréal USA has sold multi-cultural hair care brand Carol’s Daughter to an independent beauty entrepreneur with a ‘proven track record’ of acquiring and growing beauty brands, while it remains under the leadership of its founder and new President, Lisa Price.

Hungary’s Egis Picks Up Skin-Care Portfolio From Teva

 
• By 

Egis is the beneficiary as Teva again trims its OTC portfolio with the sale of Hungarian skin-care brand Neogranormon.

Alberto V05, Zest Among Iconic Brands Providing Platform For New Owner’s US Debut

 

Italian personal care and beauty manufacturer Sodalis Group will acquire Alberto V05, Zest soap, Sure deodorants and other personal care brands in a transaction with current owner Tengram Capital Partners expected to close by the end of October. Recent years have seen high private equity activity in cosmetics and personal care.

More from Strategy

Coty Establishes ‘Competitive Moat’ For Prestige Fragrance Against Upstarts, ‘Dupes’ – CEO

 

Coty Inc.’s ‘competitive moat’ against upstarts and ‘dupe” competition is a five-step strategy that includes investing in master perfumers over external suppliers and the use of ‘rare, exclusive’ ingredients in scents.

L’Oréal Heir Steps Down As Director After 28 Years; Plans to Hand Reins To Next Generation

 

L’Oréal Groupe announces company heir and 28-year Director Francoise Bettencourt Meyers plans to step down when her term expires at the end of the Annual General Meeting in April.

Estee Lauder’s Biggest Makeover Should Triple Innovation, Create ‘Flatter and Leaner’ Biz – CEO

 

New Estee Lauder President and CEO Stéphane de La Faverie unveils "Beauty Reimagined" restructuring effort to expand its recovery plan and unleash innovation to restore sustainable sales growth over next few years. The largest operational transformation in its history will include cutting up to 7,000 jobs and total charges of $1.2bn-$1.6bn, while grossing annual savings of $800m-$1bn.